The results suggested that plasma MTBR-tau243 could help estimate the tauopathy load in Alzheimer's disease, improving ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

Learn more about whether Corcept Therapeutics Incorporated or Novartis AG is a better investment based on AAII's A+ Investor ...

Novartis’ radioligand therapy Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has been approved by the US Food and Drug ...

Privately-held German radiopharmaceutical company Isotope Technologies Munich (ITM) has announced the appointment of Celine ...

BioReference Health, a biotech company, is laying off 81 employees at its main laboratory in Elmwood Park. The move comes ...

In this role, Dorelle will drive the agency’s strategic expansion, strengthen its market position, and spearhead its next ...

Unique AI for insights technology at the heart of DeepSights™ combines holistic understanding of structured and unstructured ...

In this role, Kulkarni will drive the agency’s strategic expansion, strengthen its market position, and spearhead its next ...

In this role, Kulkarni will drive the agency’s strategic expansion, strengthen its market position, and spearhead its next ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...